These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 12200603)
21. Three germline mutations in the TP53 gene. Cornelis RS; van Vliet M; van de Vijver MJ; Vasen HF; Voute PA; Top B; Khan PM; Devilee P; Cornelisse CJ Hum Mutat; 1997; 9(2):157-63. PubMed ID: 9067756 [TBL] [Abstract][Full Text] [Related]
22. Balanced t(11;15)(q23;q15) in a TP53+/+ breast cancer patient from a Li-Fraumeni syndrome family. Sherif ZA; Danielsen M Cancer Genet Cytogenet; 2006 Jul; 168(1):50-8. PubMed ID: 16772121 [TBL] [Abstract][Full Text] [Related]
23. Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer. Brugières L; Gardes M; Moutou C; Chompret A; Meresse V; Martin A; Poisson N; Flamant F; Bonaïti-Pellié C; Lemerle J Cancer Res; 1993 Feb; 53(3):452-5. PubMed ID: 8425176 [TBL] [Abstract][Full Text] [Related]
25. Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome. Wu CC; Shete S; Amos CI; Strong LC Cancer Res; 2006 Aug; 66(16):8287-92. PubMed ID: 16912210 [TBL] [Abstract][Full Text] [Related]
26. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995 [TBL] [Abstract][Full Text] [Related]
27. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457 [TBL] [Abstract][Full Text] [Related]
28. Early detection of adrenocortical carcinoma in a child with Li-Fraumeni syndrome. Lin MT; Shieh JJ; Chang JH; Chang SW; Chen TC; Hsu WH Pediatr Blood Cancer; 2009 Apr; 52(4):541-4. PubMed ID: 19101993 [TBL] [Abstract][Full Text] [Related]
29. A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family. Plummer SJ; Santibáñez-Koref M; Kurosaki T; Liao S; Noble B; Fain PR; Anton-Culver H; Casey G Oncogene; 1994 Nov; 9(11):3273-80. PubMed ID: 7936651 [TBL] [Abstract][Full Text] [Related]
30. Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome. Tabori U; Nanda S; Druker H; Lees J; Malkin D Cancer Res; 2007 Feb; 67(4):1415-8. PubMed ID: 17308077 [TBL] [Abstract][Full Text] [Related]
31. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. Malkin D; Jolly KW; Barbier N; Look AT; Friend SH; Gebhardt MC; Andersen TI; Børresen AL; Li FP; Garber J N Engl J Med; 1992 May; 326(20):1309-15. PubMed ID: 1565144 [TBL] [Abstract][Full Text] [Related]
32. p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome. Quesnel S; Verselis S; Portwine C; Garber J; White M; Feunteun J; Malkin D; Li FP Oncogene; 1999 Jul; 18(27):3970-8. PubMed ID: 10435620 [TBL] [Abstract][Full Text] [Related]
33. The first case of Li-Fraumeni syndrome in Bosnia and Herzegovina: case report. Vranic S; Kapur L; Foco F; Bilalovic N; Hainaut P Pathologica; 2006 Apr; 98(2):156-9. PubMed ID: 16929790 [TBL] [Abstract][Full Text] [Related]
34. Germ line BAX alterations are infrequent in Li-Fraumeni syndrome. Barlow JW; Mous M; Wiley JC; Varley JM; Lozano G; Strong LC; Malkin D Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1403-6. PubMed ID: 15298965 [TBL] [Abstract][Full Text] [Related]
35. Composite adrenal anaplastic neuroblastoma and virilizing adrenocortical tumor with germline TP53 R248W mutation. Rossbach HC; Baschinsky D; Wynn T; Obzut D; Sutcliffe M; Tebbi C Pediatr Blood Cancer; 2008 Mar; 50(3):681-3. PubMed ID: 17427234 [TBL] [Abstract][Full Text] [Related]
36. A rare tumor and an ethical dilemma in a family with a germline TP53 mutation. Prochazkova K; Foretova L; Sedlacek Z Cancer Genet Cytogenet; 2008 Jan; 180(1):65-9. PubMed ID: 18068537 [TBL] [Abstract][Full Text] [Related]
37. The first documentation of Li-Fraumeni syndrome in Korea. Bang YJ; Kang SH; Kim TY; Jung CW; Oh SM; Choe KJ; Kim NK J Korean Med Sci; 1995 Jun; 10(3):205-10. PubMed ID: 8527048 [TBL] [Abstract][Full Text] [Related]
38. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. Toguchida J; Yamaguchi T; Dayton SH; Beauchamp RL; Herrera GE; Ishizaki K; Yamamuro T; Meyers PA; Little JB; Sasaki MS N Engl J Med; 1992 May; 326(20):1301-8. PubMed ID: 1565143 [TBL] [Abstract][Full Text] [Related]
39. Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families. Manoukian S; Peissel B; Pensotti V; Barile M; Cortesi L; Stacchiotti S; Terenziani M; Barbera F; Pasquini G; Frigerio S; Pierotti MA; Radice P; Della-Torre G Eur J Cancer; 2007 Feb; 43(3):601-6. PubMed ID: 17224268 [TBL] [Abstract][Full Text] [Related]
40. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations. Finkova A; Vazna A; Hrachovina O; Bendova S; Prochazkova K; Sedlacek Z Cancer Genet Cytogenet; 2009 Aug; 193(1):63-6. PubMed ID: 19602465 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]